Septerna, Inc. SEC filings SEPN

Septerna, Inc. has 170 filings in SEC EDGAR's recent list, going back to Jul 13, 2023. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Septerna, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 1, 2026 —
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
3 Initial insider ownership Sep 3, 2026 Aug 24, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 12, 2026 —
144 Notice of proposed sale Aug 12, 2026 —
144 Notice of proposed sale Aug 12, 2026 —
144 Notice of proposed sale Aug 11, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
144 Notice of proposed sale Jul 15, 2026 —
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 29, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 16, 2026 Jun 12, 2026
144 Notice of proposed sale Jun 12, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction May 28, 2026 May 26, 2026
144 Notice of proposed sale May 26, 2026 —
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 20, 2026 Feb 18, 2026
144 Notice of proposed sale Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
3 Initial insider ownership Jan 15, 2026 Jan 5, 2026
4 Insider transaction Nov 13, 2025 Nov 10, 2025
144 Notice of proposed sale Nov 10, 2025 —
4 Insider transaction Sep 29, 2025 Sep 25, 2025
3 Initial insider ownership Sep 29, 2025 Sep 25, 2025
4 Insider transaction Aug 19, 2025 Aug 18, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 24, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Feb 7, 2025 Feb 7, 2025
3 Initial insider ownership Jan 7, 2025 Jan 6, 2025
SC 13D Ownership over 5% (active) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Nov 1, 2024 —
4 Insider transaction Oct 30, 2024 Oct 28, 2024
4 Insider transaction Oct 28, 2024 Oct 28, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024
3 Initial insider ownership Oct 24, 2024 Oct 24, 2024

Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SEPN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
, Emerging growth company
SEC CIK
1984086

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.